Overview Fundamentals API Earnings EOD API Sample Code Pricing

Johnson & Johnson Co DRC (JNJ BA) stock market data APIs

ARS14200 75(0.5%) as of July 26, 2024
Price chart is built with Anychart

Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke. this segment also offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures; contact lenses under the ACUVUE Brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.

Johnson & Johnson Co DRC Financial Data Overview

14125
14200
-
14300
14025
6090-14499
356 534 731 M
11.534
12 033 M
86 576 M
0.517
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'JNJ',
Type: 'Common Stock',
Name: 'Johnson & Johnson Co DRC',
Exchange: 'BA',
CurrencyCode: 'ARS',
CurrencyName: 'Argentine Peso',
CurrencySymbol: 'ARS',
CountryName: 'Argentina',
CountryISO: 'AR',
OpenFigi: NULL,
ISIN: 'ARDEUT110236',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Drug Manufacturers - General',
}

Johnson & Johnson Co DRC Fundamental Data is available in our Financial Data APIs

  • Net Revenue 86 576 M
  • EBITDA 31 147 M
  • Earnings Per Share 1226.81
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Johnson & Johnson Co DRC Earnings via APIs

  • Latest Release NaN
  • EPS/Forecast NaN

Get Johnson & Johnson Co DRC End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com